One number, honestly framed
The semaglutide page states the promotional figure and the original price in one sentence, using the seller's own word originally. That is the correct way to present a discount: the reader can see the size of it without doing any work.
It is also the only figure on the site. The original price is the nearest thing to a standing rate the seller publishes, and it is published only as the thing the promotion is measured against.
Our row carries that original figure as the price and the promotion as a first-month offer, which is the honest reading of a sentence built the way this one is.
What is missing behind it
The second month is not priced. Neither is any dose above the starting one. Neither is tirzepatide, which is a top-level navigation item on the site and carries no figure anywhere on the pages read.
Seventy-eight of the one hundred and fifty-eight sellers here carry a headline figure that is promotional, introductory, or conditioned on something the number does not disclose. Here the condition is disclosed and everything after it is missing.
That is a smaller failure than a hidden condition and a real one for anyone budgeting past the first fill.
What it does say clearly
The platform terms name the operating corporation in the opening sentence, which is clean. The site also states plainly which companies manufacture the FDA-approved semaglutide and tirzepatide products and that it is not one of them.
Both compounded drugs are top-level navigation items rather than options buried behind an intake, so the catalogue is at least visible.
No compounding pharmacy is named, no individual clinician is named, and no service area is published. Nothing is said about a membership either way.
AquaVita NextGen's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $499/mothe seller's own "originally" figure, from "we're offering Semaglutide Injectable for just $375 for your first month (originally $499)"; the page does not say what the second month costs, so this is the only standing figure it publishes | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 158 providers reviewed here are paid partners today; the other 154 are not. See how this works.
See AquaVita NextGen's current price →Good fit if
- Readers who want a first-month promotion quoted against its own list price.
- Buyers who want the operating corporation named in the terms.
- People starting compounded semaglutide who will walk the intake for month two.
Look elsewhere if
- Anyone who needs to know the ongoing price before starting.
- Buyers who want tirzepatide priced; it is offered and never costed.
- Readers who need the pharmacy or the prescriber named.
- People who need a published service area.
How this review was verified
- Read the compounded semaglutide page and the platform terms on 6 September 2026, with a nonsense-path control on the host in the same run that returned a not-found status carrying nearly four thousand characters of shell text.
- Recorded the original price as the price row and the promotion as a first-month offer, because the seller's own sentence frames it that way.
- Searched the pages read for any tirzepatide figure and found none; the absence is recorded rather than filled in.
- Screened the operating entity and the brand name against FDA's live warning-letter datatable, carrying a known letter as a positive control and a nonsense string as a negative control in the same pass; the positive control returned its letter and the negative returned nothing. Neither the entity nor the brand returned one. Untitled letters are published separately and were not searched, so the supportable claim is that no warning letter was found.